|
Market Cap (5-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 29 July 2022, 9:40. The announcement is marked as price sensitive, and is 13 page(s) in length and 1.06MB in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.011% short sold according to ASIC data. It was ranked the 629th most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 29 July 2022, 9:40 |
| Cell therapy industry leader appointed Chief Medical Officer | 25 July 2022, 9:04 |
| Change of Director's Interest Notice - GM | 7 July 2022, 11:41 |
| Appointment of VP Clinical Operations & Data Management | 5 July 2022, 10:05 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 